MGC Diagnostics (MGCD) Reports Q3 EPS of $0.06

MGC Diagnostics (NASDAQ: MGCD) reported Q3 EPS of $0.06, versus $0.80 reported last year. Revenue for the quarter came in at $9.9 million versus the consensus estimate of $9.2 million.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15